🧠 Parkinson’s Disease: Targeting Neurodegeneration with Personalised Regenerative Care

Dr. Roman
Aug 21
2 min read

Updated: Aug 22

Parkinson’s Disease is a progressive neurological condition caused by the degeneration of dopamine-producing neurons in the brain. Patients may experience tremors, rigidity, slow movement, impaired balance, and difficulties with speech, mood, and daily activities.

At BioCells Medical, we provide individualised regenerative therapy programmes aimed at supporting neuronal health, improving motor function, and slowing disease progression — always under expert neurological supervision.

💡 Who we treat

We accept patients with:

Diagnosed Parkinson’s Disease (stage 1–4)
Progressive symptoms despite medication
Non-motor symptoms affecting quality of life (fatigue, speech, cognitive issues)
Cases with atypical forms or combined symptoms (MSA overlap)

Each case is evaluated individually by our team.

🧬 What the treatment includes

Our multi-stage regenerative protocol addresses inflammation, neurodegeneration, and motor circuit activation. Depending on the clinical profile, the programme may include:

Mesenchymal Stem Cells (MSCs) — to support neural repair and reduce inflammation
T-regulatory cells — to restore immune balance in neuroinflammation
Purified exosome infusions — for cellular communication and anti-inflammatory signalling
Electro-Neuro Therapy (ENT) — to enhance motor coordination and reduce freezing episodes
Peptide-based therapy — supporting neuroplasticity and energy metabolism

All biological materials are cultivated and prepared in our certified laboratory in Warsaw.

🌍 Treatment availability

Patients can receive care:

At our Warsaw clinic, under full medical supervision
Or via international deployment, where our doctors travel to the patient for safe, protocol-based delivery

We serve families from across Europe, the Gulf region, and Central Asia.